Literature DB >> 19714751

A new tool to measure the burden of Crohn's disease and its treatment: do patient and physician perceptions match?

Allison R Wilcox1, Maria Concepcion C Dragnev, Christopher J Darcey, Corey A Siegel.   

Abstract

BACKGROUND: Health-related quality of life (HRQOL) is difficult to efficiently measure in the clinic setting. Our aim was to develop and test a simple tool to measure the burden of Crohn's disease (CD) and its treatment and to compare how patients and their physicians perceive the impact of CD on HRQOL.
METHODS: A cross-sectional, self-administered questionnaire was distributed to patients with CD. The questionnaire included a feeling thermometer to measure disease and treatment burden, which was compared to the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). At that visit, the patient's physician completed a questionnaire containing the feeling thermometer and the Harvey Bradshaw index (HBI). Nonparametric tests were use to report results.
RESULTS: In all, 113 surveys were completed. The median age of respondents was 40 years and 68% were female. Using the feeling thermometer (scale 0-100), patients reported their current health as a median of 70 (interquartile range [IQR] 50-80) and their disease specific burden as 20 (IQR 10-40). Treatment-specific burden was 6.9 (IQR 1.3-20). Physicians perceived their patients' current health as a median of 71.3 (IQR 57.5-90) with a disease burden of 12.5 (IQR 5-30). Spearman's rho between the burden of symptoms measured by the feeling thermometer and the SIBDQ was -0.71. The correlation between patient and physician perception of current health was 0.73.
CONCLUSIONS: Two questions using the feeling thermometer provide a quick and accurate assessment of the burden of CD on patients. Physicians' perception of the burden of disease was similar to their patients.

Entities:  

Mesh:

Year:  2010        PMID: 19714751      PMCID: PMC2846405          DOI: 10.1002/ibd.21094

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

1.  Symptoms and treatment burden of gastroesophageal reflux disease: validating the GERD assessment scales.

Authors:  Jean Y Liu; Steven Woloshin; William S Laycock; Richard I Rothstein; Samuel R G Finlayson; Lisa M Schwartz
Journal:  Arch Intern Med       Date:  2004-10-11

2.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

3.  Measuring quality of life in inflammatory bowel disease.

Authors:  D A Drossman
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

Review 4.  Instruments for quality of life assessment in patients with inflammatory bowel disease.

Authors:  A G Pallis; I A Mouzas
Journal:  Dig Liver Dis       Date:  2000-11       Impact factor: 4.088

5.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

6.  Quality of Life--measurement in inflammatory bowel disease.

Authors:  E J Irvine
Journal:  Scand J Gastroenterol Suppl       Date:  1993

7.  The rating form of IBD patient concerns: a new measure of health status.

Authors:  D A Drossman; J Leserman; Z M Li; C M Mitchell; E A Zagami; D L Patrick
Journal:  Psychosom Med       Date:  1991 Nov-Dec       Impact factor: 4.312

Review 8.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

9.  Beyond standard quality of life measures: the subjective experiences of living with inflammatory bowel disease.

Authors:  Barat J Wolfe; Fuschia M Sirois
Journal:  Qual Life Res       Date:  2008-06-03       Impact factor: 4.147

10.  A new measure of health status for clinical trials in inflammatory bowel disease.

Authors:  G Guyatt; A Mitchell; E J Irvine; J Singer; N Williams; R Goodacre; C Tompkins
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

View more
  6 in total

1.  Patient perception of treatment burden is high in celiac disease compared with other common conditions.

Authors:  Sveta Shah; Mona Akbari; Rohini Vanga; Ciaran P Kelly; Joshua Hansen; Thimmaiah Theethira; Sohaib Tariq; Melinda Dennis; Daniel A Leffler
Journal:  Am J Gastroenterol       Date:  2014-07-01       Impact factor: 10.864

2.  Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.

Authors:  Bijal Surti; Brennan Spiegel; Andrew Ippoliti; Eric A Vasiliauskas; Peter Simpson; David Q Shih; Stephan R Targan; Dermot P B McGovern; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2012-12-19       Impact factor: 3.199

Review 3.  Burden of treatment for chronic illness: a concept analysis and review of the literature.

Authors:  Adem Sav; Michelle A King; Jennifer A Whitty; Elizabeth Kendall; Sara S McMillan; Fiona Kelly; Beth Hunter; Amanda J Wheeler
Journal:  Health Expect       Date:  2013-01-31       Impact factor: 3.377

4.  Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions.

Authors:  Viet-Thi Tran; Victor M Montori; David T Eton; Dan Baruch; Bruno Falissard; Philippe Ravaud
Journal:  BMC Med       Date:  2012-07-04       Impact factor: 8.775

5.  Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study.

Authors:  Myrlene Sanon Aigbogun; Dorothee Oberdhan; Michael J Doane; Jillian Rooney; Brian C Inyart; Christina S Pao; Alexis H Denny
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-04-13

6.  Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

Authors:  Emma M van Andel; Brechtje D M Koopmann; Femke Crouwel; Casper G Noomen; Nanne K H de Boer; Dirk P van Asseldonk; Lidwine B Mokkink
Journal:  J Crohns Colitis       Date:  2020-09-16       Impact factor: 9.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.